Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc.

13.86
EUR
+0.12
(+0.87%)
0.12EPS
130.48P/E
1.73BMarket Cap
Mar 03Next Earn

Sarepta Therapeutics, Inc. Documents

FY2016 · Annual report

Form 10-K · 105 pages

Read Sarepta Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this annual report
Create a free account to start reading

Full documents are included with Professional

Q4 FY2016 documents